U.S. House Oversight & Reform Committee Report Shines Light on Branded Drugmakers’ Profiteering Practices, Debunks Innovation Rhetoric For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday in response to a new report from the U.S. House Committee on Oversight and Reform examining […]
Pharmaceutical Companies Increase Prices on 32 Brand Name Drugs to Start July For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday in response to a fresh round of price hikes from Big Pharma as the nation tries to recover from […]
New Report Reveals “Hidden Hand” Of Brand Name Drug Industry In case you missed it, Patients for Affordable Drugs (P4AD) released a new report Tuesday examining the financial levers and tactics used by Big Pharma to influence patient advocacy groups and a network of AstroTurf organizations to undermine support for solutions to lower drug prices […]
Pallone and Maloney Announce Joint Investigation into Massive Price Tag on Unproven Alzheimer’s Treatment as Outrage Builds For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Friday on the announcement of a joint investigation into the pricing of unproven Biogen Alzheimer’s treatment Aduhelm by Representative […]
Troubling for Public Health Institution to Depart from Established Norms to Support Drug of Questionable Efficacy with Unjustifiable Price Tag For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today reflecting on the recent U.S. Food and Drug Administration (FDA) approval of Alzheimer’s treatment […]
Campaign Calls for Promises Made to the American People to Lower Prescription Drug Prices to Become Promises Kept For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) launched new television and digital advertising Tuesday encouraging policymakers to hold brand name drug companies accountable. The ad blitz, […]
Time for the Administration and Congress to Convert Promises Made Into Promises Kept For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Friday on the release of President Biden’s Fiscal Year 2022 budget. “CSRxP commends President Biden for renewing his commitment to lowering prescription […]
Administration and Congress Must Work Together To Pass Solutions to Hold Big Pharma Accountable and Deliver Relief for American People For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Wednesday in reaction to President Biden’s comments calling for Congress to pass solutions to lower […]
Holding Big Pharma Accountable Remains Top Priority for American Voters For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Wednesday ahead of President Biden’s introduction of the “American Families Plan” in an address to Congress. “We thank the President for correctly recognizing the importance […]
Congress and the Administration Must Act on Solutions that Have Won Bipartisan Support to Deliver Relief for American Patients and Consumers For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on the reintroduction of the Elijah E. Cummings Lower Drug Costs Now Act […]